SCHEMBL19970868

SCHEMBL19970868

Cc1ccc(NC(=O)N2CCN(Cc3ccc4nc(-c5cccnc5)[nH]c4c3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
HPGD P15428 2/20 0.55
HSD17B10 Q99714 1/20 0.55
FAAH O00519 7/20 0.54
AURKA O14965 1/20 0.51
CDK1 P06493 1/20 0.51
CCNB1 P14635 1/20 0.51
CDK2 P24941 1/20 0.51
AURKB Q96GD4 1/20 0.51
TP53 P04637 4/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 1/20 0.50
DGAT1 O75907 2/20 0.49
POLB P06746 2/20 0.49
RECQL P46063 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
KIT P10721 1/20 0.48
WNT1 P04628 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19970867 0.93 FAAH (0.54) ALDH1A1HPGDHSD17B10FAAHHTT
SCHEMBL19970873 0.91 FAAH (0.61) FAAHAURKACDK1CCNB1CDK2
SCHEMBL19970830 0.90 FAAH (0.56) ALDH1A1HPGDHSD17B10FAAHAURKA
SCHEMBL19970782 0.84 FAAH (0.57) ALDH1A1HPGDHSD17B10FAAHTP53
SCHEMBL19970872 0.84 FAAH (0.61) FAAHHTTDGAT1
SCHEMBL19970829 0.83 FAAH (0.56) FAAHKIT
SCHEMBL19970728 0.80 FAAH (0.63) FAAHAURKACDK1CCNB1CDK2
SCHEMBL19986738 0.79 SLC2A1 (0.46) ALDH1A1HPGDHSD17B10FAAHAURKA
SCHEMBL19970871 0.78 FAAH (0.58) FAAHTP53HTT
SCHEMBL19970764 0.78 AURKA (0.47) ALDH1A1HPGDHSD17B10AURKACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-10-25 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
WO-2018050771-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-22 WO disclosed
EP-3296297-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-21 EP disclosed
EP-3296297-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION FIP1L1, ZC3HAV1, MAVS ALDH1A1 1822/4885HPGD 3309/4885HSD17B10 3353/4885
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection FIP1L1, ZC3HAV1, MAVS ALDH1A1 1822/4885HPGD 3309/4885HSD17B10 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.